FIELD: medicine.
SUBSTANCE: invention refers to medicine and can be used in therapy. Method for differential diagnosis of the pulmonary tissue infiltration type in pneumonia before treatment by assessing the clinical condition of the patient, as well as pulmonary tissue examination by computed tomography, spirography, general blood analysis, additionally involves determining in blood serum amount of C-reactive protein, activity of catalase, superoxide dismutase, elastase- and trypsin-like proteinases and determining discriminant functions Y1 and Y2 by equations: Y1=-28.8+0.4⋅X1+0.1⋅X2-0.01⋅X3+0.01⋅X4+3.8⋅X5; Y2=-31.0+0.1⋅X1-0.01⋅X2+0.1⋅X3+0.2⋅X4-0.6⋅X5; where X1 is the amount of C-reactive protein, mg/ml; X2 – activity of trypsin-like proteinases, nmol BAEE/min⋅ml; X3 – activity of elastase-like proteinases, nmole BANE/min⋅ml; X4 is catalase activity, mcmol/l; X5 – activity of superoxide dismutase, unit/l, and if Y1 is more than Y2, alveolar type of pulmonary infiltration is diagnosed in pneumonia, and if Y2 is more than Y1, an interstitial type of pulmonary tissue infiltration is diagnosed in pneumonia.
EFFECT: invention provides higher diagnostic accuracy that enables prescribing a pathogenetically justified therapy.
1 cl, 3 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR EVALUATING EFFECTIVENESS OF TREATMENT OF PNEUMONIA | 2020 |
|
RU2753746C1 |
DIAGNOSTIC METHOD OF COMATOSE STATE IN CASE OF PNEUMONIA | 2020 |
|
RU2738442C1 |
METHOD FOR EVALUATING EFFECTIVENESS OF TREATMENT OF PNEUMONIA | 2020 |
|
RU2753744C1 |
METHOD FOR PREDICTING COURSE OF PNEUMONIA WITH ALVEOLAR TYPE OF LUNG TISSUE INFILTRATION | 2020 |
|
RU2753745C1 |
METHOD FOR DETECTING MICROCIRCULATORY DISORDERS AS A BIOMARKER OF INTERSTITIAL CHANGES IN THE LUNGS OF PATIENTS UNDERGONE A NEW CORONAVIRUS INFECTION | 2022 |
|
RU2790513C1 |
METHOD FOR EARLY DIFFERENTIAL DIAGNOSIS OF VIRAL AND BACTERIAL COMMUNITY-ACQUIRED PNEUMONIA IN CHILDREN | 2022 |
|
RU2790239C1 |
METHOD FOR PREDICTING OUTCOME OF INFECTIOUS PROCESS AFTER A NEW CORONAVIRUS INFECTION FOR 12 MONTHS | 2023 |
|
RU2807384C1 |
METHOD FOR PREDICTION OF PROBABILITY OF POSSIBLE EXECUTION OF OPTIMUM CYTOREDUCTIVE OPERATION IN PATIENTS WITH DISSEMINATED FORMS OF OVARIAN CANCER | 2017 |
|
RU2637399C1 |
METHOD FOR DIFFERENTIAL DIAGNOSTICS OF BENIGN, PRIMARY AND SECONDARY MALIGNANT BRAIN TUMORS | 2016 |
|
RU2628816C1 |
METHOD FOR PROGNOSIS IN LINGERING PNEUMONIA COURSE IN PATIENTS WITH LIVER PATHOLOGY | 2004 |
|
RU2260803C1 |
Authors
Dates
2020-12-14—Published
2020-06-16—Filed